Lipase sales will strengthen through 2036, anchored by microbial source lipase at a 65.4% share in 2026 as the leading source segment. The market was valued at USD 1.13 billion in 2025 and is expected to reach USD 2.94 billion by 2036, creating an incremental opportunity of USD 1.71 billion.